Skip to main content
Equibles
VEEV logo

VEEV · Veeva Systems Inc · Metrics

Track VEEV — free

Use VEEV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VEEV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$323.04 +0.49 (+0.15%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$52.30B
Shares
161.91M
Volume · Oct 23 1.37M Avg daily vol (3M) 1.71M

VEEV metrics

102 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$323.04
Market cap
$52.30B

Price action

20 metrics
Price change (1W)
+4.1%
Price change (30D)
+19.3%
Price change (3M)
+73.5%
Price change (6M)
+100.5%
Price change (YTD)
+44.7%
Price change (1Y)
+10.8%
Trailing year
Price change (5Y)
+0.8%
52-week high
$323.04
52-week low
$151.43
Change from 52-week high
+0.0%
Change from 52-week low
+113.3%
Annualized volatility
43.1%
Annualized volatility (3M)
44.9%
Beta
0.6
RSI (14D)
76.2
Price vs SMA 50
+16.7%
Price vs SMA 200
+55.9%
Avg volume (3M)
1.71M
Relative volume
0.8
Average dollar volume
$449.88M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
161.91M

Valuation

12 metrics
P / E (TTM)
52.9
Trailing earnings · reciprocal yield 1.9%
PEG ratio
1.3
EV / revenue
14.6×
reciprocal yield 6.9%
EV / EBITDA
—
EV / EBIT
48.7×
reciprocal yield 2.1%
P / sales
15.1×
reciprocal yield 6.6%
P / book
7.0
reciprocal yield 14.2%
FCF yield
—
TTM · current market cap
Buyback yield
1.2%
P / FCF
—
P / operating cash flow
31.3
reciprocal yield 3.2%
Earnings yield
1.9%

Historical valuation

8 metrics
P / E historical average (3Y)
52.8×
reciprocal yield 1.9%
P / E historical average (5Y)
62.6×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
12.7×
reciprocal yield 7.9%
EV / revenue historical average (5Y)
12.7×
reciprocal yield 7.9%
EV / EBIT historical average (3Y)
51.5×
reciprocal yield 1.9%
EV / EBIT historical average (5Y)
51.5×
reciprocal yield 1.9%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.2%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-26

Profitability

9 metrics
Gross margin
75.0%
Operating margin
29.9%
Trailing 12 months
Net margin
29.3%
Gross profit (TTM)
$2.59B
Operating profit (TTM)
$1.03B
Net income (TTM)
$1.01B
Trailing 12 months
Diluted EPS (TTM)
$6.11
FCF margin
—
Effective tax rate
23.6%

Per share

11 metrics
Revenue per diluted share (TTM)
$20.81
Gross profit per diluted share (TTM)
$15.60
Operating profit per diluted share (TTM)
$6.23
EBITDA per diluted share (TTM)
$1.93
Net income per diluted share (TTM)
$6.11
Operating cash flow per diluted share (TTM)
$10.02
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$4.95
Stock compensation per diluted share (TTM)
$2.98
Book value per share
$44.05

Growth

11 metrics
Revenue growth YoY
+17.6%
Year over year
Net income growth YoY
+36.5%
Revenue (TTM)
$3.46B
Trailing 12 months
EPS growth YoY
+39.5%
Shares change YoY
-1.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+14.0%
Revenue CAGR (5Y)
+16.9%
EPS CAGR (3Y)
+21.9%
EPS CAGR (5Y)
+18.2%
FCF CAGR (3Y)
+46.9%
FCF CAGR (5Y)
+60.3%

Quality

14 metrics
Return on equity
13.7%
Return on assets
11.2%
Debt / equity
0.0
Current ratio
5.5
EBITDA (TTM)
$306.08M
Free cash flow (TTM)
—
Quick ratio
5.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
14.1%
Trailing 12 months
Net cash
$1.81B
Latest balance sheet
Cash & equivalents
$1.81B
Total assets
$9.06B
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.67B
Capital expenditures (TTM)
$1.65M
R&D (TTM)
$821.92M
SG&A (TTM)
—
Stock compensation (TTM)
$494.59M
R&D / revenue
23.8%
Stock compensation / revenue
14.3%

Ownership (13F)

9 metrics
13F filers
1,077
13F filer change QoQ
+49
Institutional ownership
90.9%
Conviction holders (share of 13F filers)
2.1%
Crowding (high-turnover and private-fund holders)
20.7%
Private-fund adviser ownership
20.2%
Active holders' share change QoQ
-4.8%
Holder tenure
17.3
Price vs estimated holder cost
-10.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.0%

Short interest

3 metrics
Short interest
3.0%
Latest settlement · 2.7 days to cover
Days to cover
2.7d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$15.18M
Insider-sentiment score
35 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1393052 CUSIP 922475108 13F (30d) 286 filings 281 filers Visit website Investor relations